Editorial Team
media age.house
The media age.house editorial team reports collaboratively on longevity science, healthspan, and the business of extending healthy human life.
Articles (15)
Longevity Minds Launches a Tokyo Community Built Around Aging
Shuzo Yamamoto and Satotaka Omori are building a Tokyo community of scientists and builders around aging, in a country where nearly 30 percent of people are already over 65.
Garmin Launches CIRQA, a Screen-Free Health and Fitness Band
Garmin’s first screenless smart band offers round-the-clock health and activity tracking, up to 10 days of battery life, and access through Garmin Connect without a Garmin subscription.
Function Secures $450M Growth Financing From General Catalyst
The preventive-health platform says the backing from General Catalyst’s Customer Value Fund will help it bring lab testing, medical imaging, and personalized health data to millions more people.
Signal Ring Opens Preorders for a Cuffless Blood-Pressure Wearable
The investigational USD 399 smart ring is designed to take on-demand and background blood-pressure readings without a cuff or calibration, with initial shipments planned for October.
Eli Lilly to Acquire AtaiBeckley for up to $3.8B, Betting Big on Psychedelic Medicine
The pharma giant is buying the clinical-stage biotech behind BPL-003 — a synthetic 5-MeO-DMT for treatment-resistant depression — in a deal that pushes psychedelic therapy firmly into the mainstream drug industry.
Neko Health Raises $700M Series C Ahead of US Launch
The preventive-scanning company co-founded by Spotify's Daniel Ek has raised one of European health tech's largest-ever rounds — backed by Lightspeed and a long list of high-profile names including Mark Zuckerberg — as it prepares to open in New York.
Beckham-Backed Supplement Brand IM8 Secures $1 Billion Financing from General Catalyst
Prenetics has landed up to $1 billion to fuel its supplement brand IM8 — but the structure is the story: no equity, no dilution. General Catalyst funds the marketing and takes a capped slice of the revenue it generates.
Functional-Drinks Brand Reformed Raises $22M Series A to Enter the US
The UK startup turns instant coffee and matcha into functional-wellness products — with collagen, creatine, and mushrooms mixed in. Two years in, it says it's already at ~$70M in annual revenue.
Anthropic Launches "Claude Science," an AI Workbench Aimed at Biology and Drug Discovery
The company behind Claude has released a research environment that pulls genomics, proteomics, and cheminformatics tools into one place — and is offering academic labs up to $30,000 in credits to try it.
Anodyne Nanotech Raises $12.6M Series A to Take a Once-Weekly GLP-1 Patch into Human Trials
The Boston biotech wants to replace the GLP-1 injection with a room-temperature patch — no needles, no cold storage. Its Series A funds the first clinical test of that idea.
Neko Health Adds Body Composition and Wearables to Its Full-Body Scan
The preventive-health company co-founded by Spotify's Daniel Ek is now measuring visceral fat and pulling in Apple Health data, pushing its one-hour scan further into everyday health tracking as it prepares to enter the US.
Insilico Medicine Signs AI Drug-Discovery Deal With SK Biopharmaceuticals Worth Up to $2.5 Billion
The AI-driven biotech will run target-to-candidate discovery for neuroimmune disorders, while its Korean partner takes the molecules through late-stage development - Insilico's largest potential deal in Asia-Pacific to date.
Midjourney Launches a Medical Division and a 60-Second Full-Body Scanner
The AI image company is moving into healthcare with "Midjourney Medical" — an ultrasonic whole-body scanner it plans to offer through its own wellness spas rather than clinics, starting in San Francisco in 2027.
Life Biosciences Doses First Patient in Landmark Trial of Cellular-Reprogramming Therapy for Vision Loss
ER-100 is one of the first attempts to take partial epigenetic reprogramming — resetting cells to a "younger" state — from the lab into a human trial. The first patient has now been dosed.
Longevity advocates to rally in 15 cities, demanding governments treat aging as a medical emergency
The April 8 coordinated action calls for dedicated public funding and a regulatory pathway for anti-aging therapies, two things that currently do not exist anywhere in the world.